LABTVSSLXN• 6 Months (Normalized)
LABT vs SLXN (Lakewood-Amedex Biotherapeutics Inc. vs Silexion Therapeutics Corp)
Showing Closing Date Range from Apr 2 to Sep 29, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
LABT Performance $0.99
-98.86%
Lakewood-Amedex Biotherapeutics Inc.
Normalized Baseline0.00%
SLXN Performance $0.32
+%
Silexion Therapeutics Corp
Normalized Baseline0.00%
Alpha Spread Margin SLXN LEADS
-98.86 pts
SLXN outperforming by 98.86 percentage points
LABTSLXN
Spread Trajectory6 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
LABT SLXN
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(124 dates)
| Date | LABT Price | LABT Gain (%) | SLXN Price | SLXN Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $0.99 | -98.86% | $- | - | |
| Sep 28, 2026 | $1.15 | -98.67% | $- | - | |
| Sep 25, 2026 | $1.67 | -98.07% | $- | - | |
| Sep 24, 2026 | $1.83 | -97.88% | $- | - | |
| Sep 23, 2026 | $1.78 | -97.94% | $0.32 | -97.40% | -0.54% |
| Sep 22, 2026 | $1.99 | -97.70% | $0.39 | -96.76% | -0.94% |
| Sep 21, 2026 | $2.05 | -97.63% | $0.54 | -95.50% | -2.13% |
| Sep 18, 2026 | $1.99 | -97.70% | $0.44 | -96.40% | -1.30% |
| Sep 17, 2026 | $1.86 | -97.85% | $0.38 | -96.86% | -0.99% |
| Sep 16, 2026 | $2.09 | -97.58% | $0.34 | -97.19% | -0.39% |
| Sep 15, 2026 | $2.17 | -97.49% | $0.34 | -97.19% | -0.30% |
| Sep 14, 2026 | $2.12 | -97.55% | $0.39 | -96.81% | -0.74% |
| Sep 11, 2026 | $2.22 | -97.43% | $0.36 | -97.05% | -0.38% |
| Sep 10, 2026 | $2.05 | -97.63% | $0.42 | -96.50% | -1.13% |
| Sep 09, 2026 | $2.32 | -97.32% | $0.35 | -97.11% | -0.21% |
Page 1 of 9